Combination of markers at the estrogen- and vitamin d-receptor genes or equivalents thereof to prognose response to osteoporosis therapy

摘要

The present invention relates to a method for determining an individual's predisposition to osteoporosis, development of osteoporosis and/or responsiveness to therapy for osteoporosis. The method comprises the step of determining the estrogen receptor genotype and the vitamin D receptor genotype of the individual, thereby determining an individual's predisposition to osteoporosis, development of osteoporosis and/or responsiveness to therapy for osteoporosis.